Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. Today’s highlights cover research that could potentially have the greatest impact to patient care for breast cancer, glioblastoma, neuroblastoma, and multiple myeloma.
Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. These studies provide a glimpse into the exciting future of precision medicine.
From June 3 to June 7, oncology professionals from around the world will meet to discuss the latest in cancer research. If you can’t wait to learn about the latest research, check here for early highlights released in advance of the 2016 ASCO Annual Meeting.
Vice President Biden’s “moonshot” to cure cancer will rely on better use of big data. CancerLinQ™ uses big data to help improve and monitor care for you and others with cancer.
With the varied recommendations surrounding breast cancer screening, how do women sort through the information and make good decisions for their health? In this interview, Connie Lehman, MD, PhD, helps decipher the recommendations for screening mammography.
How are patients’ expectations affected by the news reports of new cancer drugs?
Immunotherapy is one of the hottest topics in cancer research. This year, focus at the ASCO Annual Meeting has been on a type of immunotherapy called PD-1 inhibitors. Learn how these drugs may help improve the treatment of head and neck, liver, and lung cancers.
With the ongoing measles outbreak, how can we provide a “circle of protection” for children with cancer? Learn more from Hana Hakim, MD, an infectious diseases expert at St. Jude Children’s Research Hospital.
Dr. Anas Younes explores the recent debate over columns published in The New York Times and The Guardian and discusses how both doctors and patients use social media to talk about cancer.